FindTrial
Sign In

A study to evaluate the effect of Padabhyanga along with Tagar Churna in insomnia among elderly patients.

An Open Randomized Controlled Trial To Determine The Effect Of Padabhyanga As An Add On To Tagar Churna In Anidra W.s.r To Primary Insomnia In Geriatric Patients - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/05/110925
Enrollment
88
Registered
2026-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F99- Mental disorder, not otherwise specified

Interventions

None listed

Sponsors

Dr Kuldip Sanjay Gavande
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients clinically diagnosed with symptoms of Anidra / Primary Insomnia. 2. Geriatric patients aged more than 65 years. 3. Patients willing to participate and provide written informed consent. 4. Patients fit for Padabhyanga as per Ayurvedic parameters.

Exclusion criteria

Exclusion criteria: 1. Patients below 65 years of age. 2. Secondary insomnia due to systemic illness. 3. Insomnia due to alcoholism, injury or psychiatric disorders. 4. Patients on hypnotic or sedative medications. 5. Known allergy or hypersensitivity to study drugs/procedures

Design outcomes

Primary

MeasureTime frame
Improvement in Pittsburgh Sleep Quality Index (PSQI) Score.Timepoint: Improvement in Pittsburgh Sleep Quality Index (PSQI) Score.—

Secondary

MeasureTime frame
1. Improvement in sleep duration 2. Improvement in daytime alertness 3. Reduction in sleep disturbances 4. Assessment of tolerability of combined interventionTimepoint: Day 0 Day 7 Day 14 Day 21 Day 28—

Countries

India

Contacts

Public ContactKuldip Sanjay Gavande

Shree Saptashrungi Ayurved Mahavidyalaya and Hospital, Nashik

drkaveripatil@gmail.com8600274860

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026